An eight weeks dose-dense versus a 24 weeks sequential adriamcycin/docetaxel combination as preoperative chemotherapy (CHT) in operable breast cancer (T2-3, N0-2,M0)

✍ Scribed by G. von Minckwitz; G. Raab; M. Schuette; J.U. Blohmer; J. Hilfrich; B. Gerber; H. Eidtmann; E. Merkle; A. Caputo; M. Kaufmann

• Book ID: 117658394
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 355 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81028-5